Content about president and CEO

November 6, 2012

The New York Metro Division of H. D. Smith Wholesalers on Tuesday announced it has been preparing for the Nor'easter — anticipated to impact the northeastern United States as soon as Wednesday — by following the same emergency preparedness protocols the wholesaler had put into action both before and after Hurricane Sandy.

SPRINGFIELD, Ill. — The New York Metro Division of H. D. Smith Wholesalers on Tuesday announced it has been preparing for the Nor'easter — anticipated to impact the northeastern United States as soon as Wednesday — by following the same emergency preparedness protocols the wholesaler had put into action both before and after Hurricane Sandy. 

November 6, 2012

Coming off a strong third quarter, CVS Caremark executives expressed confidence that the company’s integrated retail/pharmacy benefit manager model and the unique programs and services it is able to deliver customers and clients are “making the difference,” president and CEO Larry Merlo told analysts during a Tuesday morning earnings call.

WOONSOCKET, R.I. — Coming off a strong third quarter, CVS Caremark executives expressed confidence that the company’s integrated retail/pharmacy benefit manager model and the unique programs and services it is able to deliver customers and clients are “making the difference,” president and CEO Larry Merlo told analysts during a Tuesday morning earnings call.

November 6, 2012

Teva Pharmaceutical Industries has made a few new executive appointments, the drug maker said Tuesday.

JERUSALEM — Teva Pharmaceutical Industries has made some new executive appointments, the drug maker said Tuesday.

Teva promoted Allan Oberman, currently SVP North America generic pharmaceuticals, to president and CEO of Teva Americas Generics. In the new role, Oberman will report directly to Teva president and CEO Jeremy Levin and have continued responsibility for generics in the North American market and overall management of the company's Latin American businesses.

November 5, 2012

Natural Products Solutions recently announced the launch of VirMax T Testosterone. As part of that launch, DSN caught up with NPS president and CEO Marty Gallant to discuss men’s health supplements. 


Natural Products Solutions recently announced the launch of VirMax T Testosterone. As part of that launch, DSN caught up with NPS president and CEO Marty Gallant to discuss men’s health supplements. 


DSN: Men aren’t too proactive addressing their own health issues. How do you market to them?


November 5, 2012

Pharmacy automation manufacturer Kirby Lester has launched a version of one of its tablet counters with streamlined verification software.

SUPPLIER NEWS — Pharmacy automation manufacturer Kirby Lester has launched a version of one of its tablet counters with streamlined verification software. The company announced the launch of KL1Plus, which it said combines the KL1 tablet counter with the updated software.


November 5, 2012

Improving medication adherence in specialty pharmacy could be equivalent to introducing a new blockbuster drug. That’s how Diplomat Specialty Pharmacy president and CEO Phil Hagerman put it at Drug Store News’ Specialty Pharmacy Roundtable two years ago. 


Improving medication adherence in specialty pharmacy could be equivalent to introducing a new blockbuster drug. That’s how Diplomat Specialty Pharmacy president and CEO Phil Hagerman put it at Drug Store News’ Specialty Pharmacy Roundtable two years ago. 


November 5, 2012

In what its president and CEO called a “significant milestone,” Watson Pharmaceuticals announced last month that the U.S. Federal Trade Commission and European Commission had approved its acquisition of Swiss generic drug maker Actavis.

In what its president and CEO called a “significant milestone,” Watson Pharmaceuticals announced last month that the U.S. Federal Trade Commission and European Commission had approved its acquisition of Swiss generic drug maker Actavis. Watson announced the $5.6 billion acquisition of Actavis in April, a deal that is expected to make Watson the third-largest generic drug maker in the world, after Teva Pharmaceutical Industries and Mylan.

November 1, 2012

AmerisourceBergen on Thursday reported revenue dropped 0.6% to $79.5 billion for its fiscal 2012 ended Sept. 30.

VALLEY FORGE, Pa. — AmerisourceBergen on Thursday reported revenue dropped 0.6% to $79.5 billion for its fiscal 2012 ended Sept. 30. Diluted earnings per share were a record $2.76, up 10% over the prior fiscal year diluted earnings per share from continuing operations. Gross profit was up 6.7% to $2.7 billion.

November 1, 2012

Lil’ Drug Store Products on Thursday announced the purchase of the Pre-Seed brand of feminine lubricant from BioOrigyn.

CEDAR RAPIDS, Iowa — Lil’ Drug Store Products on Thursday announced the purchase of the Pre-Seed brand of feminine lubricant from BioOrigyn.

November 1, 2012

Nestlé on Tuesday named Luis Cantarell head of Nestlé Nutrition with the departure of Kurt Schmidt, deputy EVP Nestlé Nutrition, who has decided to leave the company for personal reasons effective Dec. 1.

VEVEY, Switzerland — Nestlé on Tuesday named Luis Cantarell head of Nestlé Nutrition with the departure of Kurt Schmidt, deputy EVP Nestlé Nutrition, who has decided to leave the company for personal reasons effective Dec. 1. 

Cantarell will assume this role in addition to his current responsibilities as president and CEO of Nestlé Health Science. Between 2001 and 2005, he was in charge of Nestlé’s Nutrition Strategic Business Division.

November 1, 2012

Watson Pharmaceuticals is changing its name to Actavis following its acquisition of the Swiss drug maker, Watson said.

 

PARSIPPANY, N.J. – Watson Pharmaceuticals is changing its name to Actavis following its acquisition of the Swiss drug maker, Watson said.

 

Watson, whose $5.6 billion acquisition of Actavis received approval from the Federal Trade Commission earlier this month, said it would adopt the new name starting in 2013, with plans to start a multi-year rebranding campaign and trade under a new symbol on the New York Stock Exchange.

 

October 31, 2012

The Hain Celestial Group, a natural and organic products company, announced Monday the closing of the acquisition of Premier Food's portfolio of packaged grocery brands and its Histon manufacturing base in Cambridgeshire, United Kingdom.

MELVILLE, N.Y. – The Hain Celestial Group, a natural and organic products company, announced Monday the closing of the acquisition of Premier Food's portfolio of packaged grocery brands and its Histon manufacturing based in Cambridgeshire, United Kingdom.

"This acquisition furthers our goal to expand in the United Kingdom, and positions the newly expanded Hain Daniels business in the top 40 of all food and beverage suppliers in the U.K.," said Irwin Simon, founder, president and CEO of Hain Celestial.

October 31, 2012

Watson Pharmaceuticals on Wednesday announced the sale of its Rugby over-the-counter business to the Harvard Drug Group — a distributor and provider of private-label OTCs and generic prescription products under the Major Pharmaceuticals brand — for approximately $117 million.

PARSIPPANY, N.J. — Watson Pharmaceuticals on Wednesday announced the sale of its Rugby over-the-counter business to the Harvard Drug Group — a distributor and provider of private-label OTCs and generic prescription products under the Major Pharmaceuticals brand — for approximately $117 million.  

"I am confident that Major, with its leadership position as a marketer of OTC products, will be more strategically positioned to maximize the value of the long-known and respected Rugby name," stated Paul Bisaro, president and CEO of Watson.

October 29, 2012

AmerisourceBergen on Monday named Lawrence Marsh, 52, to the new role of chief strategy officer and SVP new market development, effective Nov. 12, 2012.

VALLEY FORGE, Pa. — AmerisourceBergen on Monday named Lawrence Marsh, 52, to the new role of chief strategy officer and SVP new market development, effective Nov. 12, 2012. 

October 29, 2012

Ulta Beauty has announced that Michael MacDonald, president and CEO of DSW, a branded footwear and accessories retailer, has been appointed to its board.

BOLINGBROOK, Ill. — Ulta Beauty has announced that Michael MacDonald, president and CEO of DSW, a branded footwear and accessories retailer, has been appointed to its board.

October 26, 2012

In addition to an extensive structural makeover, dubbed the "Growth Game Plan", Newell Rubbermaid president and CEO Mike Polk announced a new leadership team that includes outside appointments to several executive positions.

ATLANTA – In addition to an extensive structural makeover, dubbed the "Growth Game Plan", Newell Rubbermaid president and CEO Mike Polk announced a new leadership team that includes outside appointments to several executive positions.

October 25, 2012

The leader of pharmacy benefit manager Prime Therapeutics will be the keynote speaker at a specialty pharmacy conference Thursday.

ST. PAUL, Minn. — The leader of pharmacy benefit manager Prime Therapeutics will be the keynote speaker at a specialty pharmacy conference Thursday.

Prime said president and CEO Eric Elliott would deliver the keynote speech, titled "Specialty Pharmacy Benefit - The Employer's Perspective" at the first annual Therigy Specialty Pharmacy Leadership Congress in Orlando, Fla.

October 23, 2012

New York’s hip and edgy beauty retailer Ricky’s NYC has tapped Catherine Moellering, former EVP at the retail consultancy Tobe Report, to serve as its new president and CEO, according to a published report.

NEW YORK — New York’s hip and edgy beauty retailer Ricky’s NYC has tapped Catherine Moellering, former EVP at the retail consultancy Tobe Report, to serve as its new president and CEO, according to a published report.

According to a Crain’s report, Moellering joined Ricky's in order to better position the brick-and-mortar business for the digital revolution.

October 18, 2012

CVS Caremark announced on Thursday the appointment of Alan Lotvin to the position of EVP specialty pharmacy.

WOONSOCKET, R.I. — CVS Caremark announced on Thursday the appointment of Alan Lotvin to the position of EVP specialty pharmacy.

Lotvin has extensive experience in the pharmacy benefit management and specialty pharmacy industries. Prior to joining CVS Caremark, Lotvin was president and CEO of Icore Healthcare, a Magellan Health Services company. Previously, he has held roles as president and COO of M|C Communications, a medical education provider, and served in various senior management positions at Medco Health Solutions, including president of specialty pharmacy services.

October 11, 2012

Steve Mister, president and CEO for the Council for Responsible Nutrition, last week was named one of the year’s top CEOs by CEO Update, the publication that covers executive careers in associations, nonprofits and professional societies.

WASHINGTON — Steve Mister, president and CEO for the Council for Responsible Nutrition, last week was named one of the year’s top CEOs by CEO Update, the publication that covers executive careers in associations, nonprofits and professional societies.   

October 11, 2012

A coalition — which includes the California Medical Association, the California Dental Association, California Pharmacists Association, National Association of Chain Drug Stores, California Association of Medical Product Suppliers, AIDS Healthcare Foundation and American Medical Response — continues to work to block the state of California from cutting Medi-Cal reimbursement rates by 10%.

SACRAMENTO, Calif. — A coalition — which includes the California Medical Association, the California Dental Association, California Pharmacists Association, National Association of Chain Drug Stores, California Association of Medical Product Suppliers, AIDS Healthcare Foundation and American Medical Response — continues to work to block the state of California from cutting Medi-Cal reimbursement rates by 10%.

October 10, 2012

Nipro Diagnostics on Wednesday announced the introduction of a new portfolio of more than 30 ancillary products targeted to meet the needs of individuals with diabetes.

FORT LAUDERDALE, Fla. — Nipro Diagnostics on Wednesday announced the introduction of a new portfolio of more than 30 ancillary products targeted to meet the needs of individuals with diabetes. The TruePlus products are designed to offer innovative, affordable solutions for diabetes patients to lead healthier lives.

October 9, 2012

With healthcare reform on track to bring 32 million more Americans into the healthcare system in 2014, and with payers and patients looking for solutions to curb costs as the nation battles a shortage of primary care physicians and access to quality care, CVS Caremark’s role in reinventing pharmacy through its distinctive business model couldn’t be more imperative than it is today.


With healthcare reform on track to bring 32 million more Americans into the healthcare system in 2014, and with payers and patients looking for solutions to curb costs as the nation battles a shortage of primary care physicians and access to quality care, CVS Caremark’s role in reinventing pharmacy through its distinctive business model couldn’t be more imperative than it is today.


October 9, 2012

With its sights firmly fixed on delivering innovative solutions that address emerging customer needs that no stand-alone PBM or stand-alone retail pharmacy could provide, CVS Caremark is seeing growing interest in its proprietary programs — or integration sweet spots — known as Maintenance Choice and Pharmacy Advisor.


With its sights firmly fixed on delivering innovative solutions that address emerging customer needs that no stand-alone PBM or stand-alone retail pharmacy could provide, CVS Caremark is seeing growing interest in its proprietary programs — or integration sweet spots — known as Maintenance Choice and Pharmacy Advisor.


October 9, 2012

While CVS/pharmacy’s store clustering initiatives and store brands are fueling front-store profitability, there’s no doubt that its successful, long-standing ExtraCare loyalty program remains a key driver of front-store sales, and it arms the company with a powerful competitive advantage, especially as CVS looks to take the program to new heights. 


While CVS/pharmacy’s store clustering initiatives and store brands are fueling front-store profitability, there’s no doubt that its successful, long-standing ExtraCare loyalty program remains a key driver of front-store sales, and it arms the company with a powerful competitive advantage, especially as CVS looks to take the program to new heights.